Cleveland Clinic Uses Noninvasive Ultrasound Technology to Treat Some Liver Tumors

April 29, 2024, Cleveland: Global health system Cleveland Clinic has started using a recently FDA-approved ultrasound device to treat liver tumors. The non-invasive technology, called histotripsy, uses brief high-intensity ultrasound pulses that disrupt and kill the targeted tumor cells.

Cleveland Clinic Expert Shares Four Diabetes-Management Strategies for Ramadan

Endocrinologist from global health system offers wellness tips and highlights why individuals should know their blood sugar numbers and how new-technology monitors can help

March 4, 2024, CLEVELAND: Many people with diabetes are able to fast safely and enjoy the full spiritual, physical and mental health benefits of Ramadan, provided they are medically cleared and take some necessary precautions, says an expert from global health system Cleveland Clinic.

“Alongside spiritual practices, charitable endeavors and spending time with loved ones, people with diabetes can focus on improving their health during Ramadan,” says endocrinologist Hasan A. Husni, M.D. “Lifestyle factors such as a poor diet, carrying excess weight, smoking and lack of exercise can all have a negative impact on blood sugar and insulin levels, making diabetes more difficult to manage. Ramadan provides an ideal opportunity to focus on adopting a healthier lifestyle that reduces or eliminates these diabetes risk factors, while also reducing cholesterol levels and improving cardiovascular health.”

Researchers from Global Health System Cleveland Clinic and IBM Publish Findings on Artificial Intelligence and Immunity

• Study highlights how AI can be designed to develop better immunotherapy treatments
• Timothy Chan M.D. Ph.D., who co-led the study, holds the Sheikha Fatima Bint Mubarak Endowed Chair in Immunotherapy and Precision Immuno-Oncology

February 6, 2024, CLEVELAND: Researchers from global health system Cleveland Clinic and IBM have published a strategy for identifying new targets for immunotherapy through artificial intelligence (AI). This is the first peer-reviewed publication from the two organizations’ Discovery Accelerator partnership, designed to advance research in healthcare and life sciences.

New Medications and Emerging Therapies are Improving Quality of Life for Individuals with Chronic Migraines, says Cleveland Clinic Expert

Development of migraine-specific drugs to prevent and relieve the debilitating condition are proving highly effective, says a headache specialist

September 7, 2023, CLEVELAND: Medications developed over the past few years to treat migraines are significantly improving the quality of life for those with the debilitating condition, according to an expert from global health system Cleveland Clinic.

“Before 2018, when the FDA-approved the first calcitonin gene-related peptide (CGRP) inhibitor to prevent migraines, we had to rely on medications originally designed to treat other diseases, says Emad Estemalik MD, MBA, Section Head for Headache and Facial Pain at Cleveland Clinic’s Neurological Institute. “Today, however, there are several CGRP inhibitors available that have been developed to prevent or to relieve the symptoms of migraines specifically.”